Laxido Junior

Macrogol 3350, the active ingredient in Laxido Junior, is an osmotic laxative presented as an oral powder for solution for oral use. The formulation combines sodium hydrogen carbonate, potassium chloride and sodium chloride to maintain electrolyte balance while increasing intestinal water content. It is indicated for the treatment of constipation in children, including functional constipation.

GNH USA supplies Laxido Junior as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to EU manufacturing standards and providing reliable global distribution.

Laxido Junior, an osmotic laxative, is used to manage pediatric constipation and related functional bowel disorders.

Constipation in children: softens stool and facilitates regular bowel movements. Functional constipation: improves stool consistency and reduces abdominal discomfort. Chronic constipation: provides long‑term relief by maintaining intestinal hydration.

Laxido Junior may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Abdominal bloating - Flatulence - Nausea - Mild diarrhea - Abdominal cramps - Increased thirst

Serious or Rare Side Effects: - Severe dehydration - Electrolyte imbalance - Allergic reaction (rash, itching, swelling) - Severe abdominal pain - Rectal bleeding - Anaphylaxis

When using Laxido Junior, certain precautions should be observed to ensure safety and effectiveness.

Dose adjustment: tailor the dose to the child's age and weight under medical supervision. Electrolyte monitoring: assess serum electrolytes during prolonged therapy or in patients with renal disease. Renal impairment: use cautiously in children with compromised kidney function. Use in children: ensure the appropriate pediatric formulation and dosage are applied. Avoid concurrent use with other laxatives: prevent additive osmotic load. Store at ambient temperature: keep in the original packaging, protect from moisture.

Laxido Junior can interact with other medicines; some combinations should be avoided while others require monitoring.

Major Interactions (Avoid): - Concurrent use with high‑dose electrolyte solutions: risk of electrolyte overload. - Co‑administration with mineral oil: may reduce efficacy of both agents.

Moderate Interactions (Monitor Closely): - Diuretics: monitor electrolytes due to additive fluid loss. - Anticholinergic drugs: may diminish laxative effect. - Other osmotic laxatives (e.g., lactulose): increase risk of diarrhea and electrolyte disturbance.